Home
News
Site Map
Search Advanced Search
News
EDITOR'S CHOICE
NEWS
Builder offers reward after van stolen
Government pledge on cancer-drugs lottery
OXFORD UNITED
FOOTBALL: U's players set for hard slog
EATING OUT
The Black Horse, Checkendon
CRICKET
CRICKET: Challow close in on leaders
CRICKET: Shrivenham miss out on final place
NEWS
Update: UK 'ill prepared' for floods
VOTE
Is it right that cancer patients should have to pay for their own treatment?
Yes
No
GET OUR NEWS BY E-MAIL
Most read Comments
Acne drug under the spotlight

Scientists at an Oxfordshire biotech firm have made a breakthrough in the treatment of acne.

Experts at Summit, based at Milton Park, near Didcot, have developed a new drug which has been found to cut the production of sebum, a fatty substance produced by glands in the skin. Excessive production of sebum is a primary cause of acne.

Clinical trials of the drug, known as SMT D002, revealed that sebum production was reduced by 90 per cent among 18 healthy volunteers.

It is estimated there are 54 million acne sufferers in the developed world with about eight million of those resistant to common treatments.

Bosses now plan to develop the drug in cream form and are looking for a partner to ensure it reaches the market.

10:28am Tuesday 15th April 2008

Print   Email this
Archive
Bride and Groom Oxfordshire'
Choose from more than 35,000 Jobs, Homes and Cars in Abingdon and Oxfordshire
Powered by Powered by Fish4
Reader Holidays
Exclusive to this site and are not available on the high street
Buy photos
You can buy online photos that have appeared in the Herald.
Terms & Conditions
Privacy Policy © Copyright 2001-2008
Newsquest Media Group
A Gannett Company
This site is part of Newsquest's audited local newspaper network